Benicar (olmesartan), a new angiotensin receptor blocker for hypertension

May 2002

Reps will soon be promoting Benicar (olmesartan), a new angiotensin receptor blocker for hypertension.

It will be the seventh one on the market...after Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), Atacand (candesartan), Micardis (telmisartan), and Teveten (eprosartan).

Reps might tell you that Benicar is more effective...but don't get too excited. It's pretty much a "me-too."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote